- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06521021
CHOICE to AVOID or RESIST
CHOICE to AVOID or RESIST: Evaluating Participants' Choice of Self-regulatory Strategy on Weight Management Outcomes: A Pilot Study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Since we initiated recruitment for the AVOID/RESIST trial (IRB STUDY00001652: AVOID-RESIST), we have noted that some participants have a strong initial inclination for one of the self-regulatory strategies. Some individuals have clearly expressed which strategy they believed would work for them, while others have voiced dislike or skepticism for an assigned intervention component. While attrition in the last 18 months (12.5%) is comparable to trials of similar size and scope, over 56% (n=18) of withdrawals were explicitly (n=3) or tangentially (n=15) related to intervention assignment.
This pilot study (CHOICE) seeks to leverage our ongoing R01 to test whether participants' active choice of behavior change pathways and strategies leads to better adherence, retention, and engagement. Consistent with ongoing procedures, women, and men with overweight or obesity (BMI between 25-45 kg/m2) will be enrolled in the WW digital program for 12 months. R01 participants will continue to be randomized to one of the 4 study arms: (1) WW alone, (2) WW + AVOID, (3) WW + RESIST, (4) WW + AVOID + RESIST. CHOICE participants will be asked to choose which self-regulatory strategy (AVOID or RESIST) they want to receive to promote behavior change consistent with WW recommendations.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julissa Ruiz, BS
- Phone Number: (310) 602-4169
- Email: julissa.ruiz@cshs.org
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 years or older
- BMI between 25-45 kg/m2
- Read, write, and speak English with acceptable visual acuity
Exclusion Criteria:
- Currently enrolled in weight loss interventions or undergoing bariatric surgery
- Pregnant women
- Individuals for whom weight loss may be contraindicated (e.g., unstable coronary artery disease, end-stage disease, active cancer treatment, uncontrolled insulin-dependent diabetes, portal hypertension, drug/alcohol abuse)
- Individuals who have pacemakers or other electronic medical device implantations
- Individuals with severe cognitive delays or visual/hearing impairment
- Individuals who are unable or unwilling to complete the study assessments / measurements
- Individuals currently subscribed to a meal delivery service who are unwilling to pause their subscription for the duration of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: WW + Home modification and grocery delivery (AVOID)
WW + modification of home food environment + online grocery shopping and delivery Arm assignment is selected by participant. |
Behavioral: Home food environment and grocery delivery (AVOID) Participants will receive coaching (Zoom and/or email/text) to modify their home food environment and alter cues to promote healthy food choices Behavioral: WW Participants assigned to all arms will receive of coaching (Zoom and/or email/text) and commercially-available weight management program focusing on diet, physical activity and mindset skills. |
|
Other: WW + Inhibitory control training (RESIST)
WW + daily gamified inhibitory control training Arm assignment is selected by participant. |
Behavioral: Inhibitory control training (RESIST) Participants assigned to RESIST will receive coaching (Zoom and/or email/text) and gamified inhibitory control training. Behavioral: WW Participants assigned to all arms will receive coaching (Zoom and/or email/text) and commercially-available weight management program focusing on diet, physical activity and mindset skills. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Follow-up Completion
Time Frame: Baseline, 6 Month
|
We will continuously track the rate of 6-month follow-up completion as followed: actual follow-ups completed / expected follow-ups to be completed.
|
Baseline, 6 Month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: Baseline
|
Participant baseline height is self-reported in inches.
|
Baseline
|
|
Demographics
Time Frame: Baseline
|
Demographic questionnaire will be used to capture date of birth, sex and gender identity, race, ethnicity, socioeconomic status (education, household income, marital status, employment status) and household composition (e.g., multigenerational, children).
|
Baseline
|
|
Drivers of preference, retention, and adherence
Time Frame: Baseline, 6 Month
|
Our quantitative analytic approach will make it possible to compare CHOICE and RANDOM study follow-up completion, adherence, and weight loss among Non-Hispanic White and among those who identify to an ethnic and/or racial minoritized group.
Quantitative analyses, however, do not make it possible to contextualize drivers that may influence relative preference, retention, and adherence.
Using semi-structured interviews (Appendix A), we will explore the depth of personal beliefs and experiences, cultural contexts, social dynamics, social support systems, and household factors that may influence affect participants' preferences and sustained engagement.
This knowledge will inform personalized behavior change strategies that are sensitive to the diverse needs of participants' social context.
|
Baseline, 6 Month
|
|
Weight
Time Frame: Baseline, 6 Month
|
Weight is measured using the Bluetooth enabled scales based on standard practices (e.g., empty pockets).
Weight loss will be operationalized as the difference between weight at baseline and 6mo.
|
Baseline, 6 Month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary intake and physical activity
Time Frame: Baseline, 6 Month
|
We will leverage data conferred by the WW program to capture dietary intake and physical activity (type, duration and intensity) via the WW mobile app or online website.
|
Baseline, 6 Month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sarah Salvy, PhD, Cedars-Sinai Medical Center
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003315
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerRecruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Massachusetts General HospitalDenver Health and Hospital Authority; Prisma Health-UpstateCompletedOverweight and Obesity | Severe ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
Clinical Trials on AVOID
-
University of TorontoUniversity Health Network, Toronto; Nihon KohdenUnknownVentilator-Induced Lung Injury | Respiratory Distress Syndrome, AdultCanada
-
Clinica Universidad de Navarra, Universidad de...Not yet recruitingDrainage | Distal Pancreatectomy | Postoperative Pancreatic Fistula
-
University of California, San FranciscoTerminatedStroke | Catheter Associated Urinary Tract InfectionUnited States
-
University of California, San FranciscoCompletedAtrial Fibrillation | CoffeeAustralia, United States, Canada
-
University of RochesterNational Institute of Nursing Research (NINR)Completed
-
Jeong Eon LeeAsan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital and other collaboratorsActive, not recruiting
-
Mansoura UniversityRecruitingBladder Cancer Stage IEgypt
-
Gorm GreisenCopenhagen Trial Unit, Center for Clinical Intervention Research; Elsass FoundationCompletedBrain Injuries | Infant, Extremely Premature | Death; Neonatal | Death, BrainDenmark
-
Cedars-Sinai Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The... and other collaboratorsRecruiting
-
Georgetown UniversityInstitute for Reproductive Health, Georgetown University; Cycle Technologies; EastBanc TechnologiesCompleted